Status:
COMPLETED
A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy
Lead Sponsor:
Brooke Army Medical Center
Conditions:
Colonoscopy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Miralax (PEG 3350) has been shown to be a safe and uncomplicated bowel preparation prior to colonoscopy in pediatric populations. This study seeks to confirm the efficacy of this bowel cleansing regim...
Eligibility Criteria
Inclusion
- adult patients referred to our clinic for average or increased risk screening for colorectal cancer
Exclusion
- elevated serum creatinine (Men \>1.4mg/dL, Women \>1.3mg/dL)
- previous diagnosis of congestive heart failure
- history of bowel obstruction
- history of solid organ transplant
- current pregnancy
- lactating mother
- participants allergic to either polyethylene glycol (Miralax), lubiprostone (Amitiza), or bisacodyl (Dulcolax)
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
425 Patients enrolled
Trial Details
Trial ID
NCT00953017
Start Date
July 1 2009
End Date
May 1 2010
Last Update
November 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brooke Army Medical Center
San Antonio, Texas, United States, 78248